Genetic Technologies Limited (GENE)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.07M |
| Enterprise value | 8.83M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.53 |
| Price/book (mrq) | 3.17 |
| Enterprise value/revenue | 1.55 |
| Enterprise value/EBITDA | -2.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | -53.27% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 5.9000 |
| 52-week low 3 | 1.8000 |
| 50-day moving average 3 | 2.6086 |
| 200-day moving average 3 | 3.0051 |
Share statistics
| Avg vol (3-month) 3 | 34.4k |
| Avg vol (10-day) 3 | 21.12k |
| Shares outstanding 5 | 4.41M |
| Implied shares outstanding 6 | 24.81M |
| Float 8 | 103.49M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 1.33% |
| Shares short (30 Apr 2024) 4 | 15.66k |
| Short ratio (30 Apr 2024) 4 | 0.86 |
| Short % of float (30 Apr 2024) 4 | N/A |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.58% |
| Shares short (prior month 28 Mar 2024) 4 | 11.53k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 15 Aug 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 14 Dec 2023 |
Financial highlights
Currency in AUD.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -124.08% |
| Operating margin (ttm) | -105.96% |
Management effectiveness
| Return on assets (ttm) | -52.71% |
| Return on equity (ttm) | -160.47% |
Income statement
| Revenue (ttm) | 10.24M |
| Revenue per share (ttm) | 2.73 |
| Quarterly revenue growth (yoy) | -2.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -9.86M |
| Net income avi to common (ttm) | -12.71M |
| Diluted EPS (ttm) | -0.1500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 3.73M |
| Total cash per share (mrq) | 0.03 |
| Total debt (mrq) | 382.32k |
| Total debt/equity (mrq) | 7.95% |
| Current ratio (mrq) | 1.67 |
| Book value per share (mrq) | 0.04 |
Cash flow statement
| Operating cash flow (ttm) | -7.6M |
| Levered free cash flow (ttm) | -4.6M |
© 2024 Yahoo. All rights reserved.